Roy Gulick to Double-Blind Method
This is a "connection" page, showing publications Roy Gulick has written about Double-Blind Method.
Connection Strength
0.103
-
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial. Ann Intern Med. 2017 Sep 19; 167(6):384-393.
Score: 0.076
-
Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359. J Infect Dis. 2002 Sep 01; 186(5):626-33.
Score: 0.027